Searched for
GSK INDIA RESULTS
Will PLI help Indian pharma gain market share at cost of MNCs?Indian pharmaceutical companies are becoming more aggressive and increasing their market share and capex. Companies such as Divis, Dr Reddy...31 Aug, 2022, 03.25 PM IST- GSK mulls tech captive in India, may reduce outsourcing to Indian ITGSK, which outsources technology services to Indian IT companies such as Tata Consultancy Services and Infosys and others, is looking to fo...09 Jul, 2020, 05.49 PM IST
- GSK's tuberculosis vaccine shows promising resultsThe new vaccine, known as M72/AS01E, was tested at 11 sites in Kenya, South Africa and Zambia in adults whose blood tests showed they had l...29 Oct, 2019, 01.40 PM IST
- GSK to recall Ranitidine from India after regulator alertBritish drugmaker will suspend release, distribution and supply of the heartburn drug.26 Sep, 2019, 08.20 AM IST
- Unilever used HUL buyback gains to secure GSK health dealUnilever bought back HUL shares at Rs 600 apiece 5 years ago which has appreciated to Rs 1,700 now. Unilever diluted 5.3% HUL stake in GSK ...11 Dec, 2018, 07.41 AM IST
- Considering possible deal and merger of Indian unit: GlaxoSmithKlineIn response to recent press speculation, GSK confirms that consideration is being given to a potential transaction that includes a merger o...29 Nov, 2018, 11.46 PM IST
- Danone, HUL, KKR vie for GSK’s consumer businessAs per Monday’s market value, 72 per cent of GSK is worth around Rs 17,980 crore.23 May, 2018, 09.50 AM IST
- ITC likely to be a strong contender to buy GSK's nutrition business including HorlicksNestle, Unilever, PepsiCo may look to buy its nutrition business, but ITC ‘likely strong contender’ as malt-based brands can expand its por...29 Mar, 2018, 08.38 AM IST
- GSK may put iconic Horlicks for sale to fund $13-billion Novartis dealGSK is initiating a strategic review of Horlicks and its other consumer healthcare nutrition products to support funding the Novartis deal.28 Mar, 2018, 11.22 AM IST
- We will offer India new drugs at reasonable price: Andrew Witty, global CEO, GlaxoSmithKlineWitty talks about GSK’s India plans, the local IP laws and the debate on high pricing of drugs. Edited excerpts:02 Feb, 2016, 04.00 AM IST
- GSK Pharma's Bengaluru facility to be operational by 2017GSK India has said its greenfield manufacturing facility at Bengaluru, having an installed capacity of over 9 billion tablets and capsules ...02 Aug, 2015, 01.58 PM IST
- Competition Commission of India clears Novartis-GlaxoSmithKline pharma dealThe multi-layered deal involves UK-based GlaxoSmithKline acquiring Novartis's vaccine biz, while latter would purchase GSK's cancer drugs p...23 Dec, 2014, 08.48 PM IST
- GlaxoSmithKline to spend $1 billion to raise stake in Indian pharma unitGSK said that it was looking to buy a 24% stake in the pharmaceuticals subsidiary for about $1billion or Rs 6,400 crore.17 Dec, 2013, 05.50 AM IST
- Glaxo’s plan to acquire 5% stake in Dr Reddy’s may fizzle outUK-BASED GlaxoSmithKline’s (GSK) plan to buy about 5% stake in Dr Reddy’s Laboratories (DRL) for $150-160 million is stuck and unlikely to ...24 Feb, 2010, 12.48 AM IST
- GSK drops claims on two AIDS medicinesIn a relief to around 2.5 million HIV patients and generic firms like Cipla and Ranbaxy, GlaxosmithKline (GSK) has pulled out the patent ap...07 Dec, 2007, 01.11 AM IST
- Glaxo, Ranbaxy expand R&D dealRanbaxy Laboratories announced on Tuesday the signing of a new multi-year R&D agreement with GlaxoSmithKline (GSK), which expands the terms...07 Feb, 2007, 01.17 AM IST
- GSK plans revamp for 3-fold rise in salesIndia’s largest drug maker GlaxoSmithKline, which announced changes in its top management on Thursday, is gearing up for a major realignmen...23 Sep, 2006, 02.51 AM IST
Load More
